PT - JOURNAL ARTICLE AU - John S. Albin AU - Jacob E Lazarus AU - Kristen M. Hysell AU - David M. Rubins AU - Lindsay Germaine AU - Caitlin M. Dugdale AU - Howard M. Heller AU - Elizabeth L. Hohmann AU - Joshua J. Baugh AU - Erica S. Shenoy TI - Development and implementation of a clinical decision support system tool for the evaluation of suspected monkeypox infection AID - 10.1101/2022.08.15.22278791 DP - 2022 Jan 01 TA - medRxiv PG - 2022.08.15.22278791 4099 - http://medrxiv.org/content/early/2022/08/17/2022.08.15.22278791.short 4100 - http://medrxiv.org/content/early/2022/08/17/2022.08.15.22278791.full AB - Monkeypox virus was historically rare outside of West and Central Africa until the current 2022 global outbreak, which has required clinicians to be alert to identify individuals with possible monkeypox, institute isolation, and take appropriate next steps in evaluation and management. Clinical decision support systems (CDSS), which have been shown to improve adherence to clinical guidelines, can support frontline clinicians in applying the most current evaluation and management guidance in the setting of an emerging infectious diseases outbreak when those guidelines are evolving over time. Here we describe the rapid development and implementation of a CDSS tool embedded in the electronic health record to guide frontline clinicians in the diagnostic evaluation of monkeypox infection and triage patients with potential monkeypox infection to individualized infectious diseases physician review. We also present data on the initial performance of this tool in a large integrated healthcare system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by US Assistant Secretary for Preparedness and Response (6 U3REP150548-05-08 to ESS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted under Mass General Brigham IRB protocol 2012P002359.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying this article cannot be shared publicly due to the privacy of individuals that participated in the study.